Volume 24, Issue 10, Pages e5 (September 2018)

Slides:



Advertisements
Similar presentations
Figure 5 ISOX and vorinostat partially restore splicing pattern in DM1 patient-derived fibroblasts. (A) ISOX and vorinostat partially rescue mis-splicing.
Advertisements

Johanna Sigl-Glöckner, Michael Brecht  Cell Reports 
Volume 26, Issue 2, Pages (January 2016)
Volume 26, Issue 14, Pages (July 2016)
A MicroRNA124 Target Sequence Restores Astrocyte Specificity of gfaABC1D-Driven Transgene Expression in AAV-Mediated Gene Transfer  Grit Taschenberger,
Volume 82, Issue 6, Pages (June 2014)
Volume 22, Issue 1, Pages 8-16 (January 2018)
Molecular Therapy - Methods & Clinical Development
Molecular Therapy - Nucleic Acids
Volume 21, Issue 12, Pages (December 2017)
Molecular Therapy - Nucleic Acids
Volume 25, Issue 6, Pages (June 2017)
Volume 23, Issue 5, Pages (May 2018)
Volume 27, Issue 16, Pages e3 (August 2017)
Euiseok J. Kim, Matthew W. Jacobs, Tony Ito-Cole, Edward M. Callaway 
Volume 15, Issue 7, Pages (May 2016)
Engineered Exosomes as Vehicles for Biologically Active Proteins
Volume 87, Issue 6, Pages (September 2015)
Selection and Identification of Skeletal-Muscle-Targeted RNA Aptamers
Minimal Purkinje Cell-Specific PCP2/L7 Promoter Virally Available for Rodents and Non- human Primates  Keisuke Nitta, Yasunori Matsuzaki, Ayumu Konno,
Volume 22, Issue 4, Pages (January 2018)
Volume 47, Issue 3, Pages e4 (September 2017)
Volume 7, Issue 3, Pages (September 2016)
Johanna Sigl-Glöckner, Michael Brecht  Cell Reports 
Volume 24, Issue 5, Pages (May 2016)
Volume 16, Issue 3, Pages (March 2015)
Volume 12, Issue 4, Pages (October 2005)
Volume 16, Issue 6, Pages (August 2016)
Axonal swelling and impairment of dendritic development in Purkinje cells from Pex14ΔC/ΔC BL/ICR mouse upon treatment with BDNF. Axonal swelling and impairment.
Volume 68, Issue 3, Pages e9 (November 2017)
Volume 19, Issue 3, Pages (September 2016)
Shane M. Harding, Jonathan A. Boiarsky, Roger A. Greenberg 
Lauren M. Tanabe, Chun-Chi Liang, William T. Dauer  Cell Reports 
Molecular Therapy - Methods & Clinical Development
Volume 23, Issue 4, Pages (April 2018)
Volume 25, Issue 10, Pages (October 2017)
Volume 20, Issue 6, Pages (August 2017)
Volume 13, Issue 6, Pages (November 2015)
ADAR Regulates RNA Editing, Transcript Stability, and Gene Expression
Alterations in mRNA 3′ UTR Isoform Abundance Accompany Gene Expression Changes in Human Huntington’s Disease Brains  Lindsay Romo, Ami Ashar-Patel, Edith.
Volume 15, Issue 12, Pages (June 2016)
Volume 23, Issue 7, Pages (May 2018)
Volume 2, Issue 3, Pages (September 2012)
An Intrinsic Epigenetic Barrier for Functional Axon Regeneration
Activin Signals through SMAD2/3 to Increase Photoreceptor Precursor Yield during Embryonic Stem Cell Differentiation  Amy Q. Lu, Evgenya Y. Popova, Colin.
Volume 26, Issue 19, Pages (October 2016)
Corticostriatal Transmission Is Selectively Enhanced in Striatonigral Neurons with Postnatal Loss of Tsc1  Katelyn N. Benthall, Stacie L. Ong, Helen S.
Evidence for an Age-Dependent Decline in Axon Regeneration in the Adult Mammalian Central Nervous System  Cédric G. Geoffroy, Brett J. Hilton, Wolfram.
Volume 27, Issue 6, Pages e6 (May 2019)
Rational Design of Therapeutic siRNAs: Minimizing Off-targeting Potential to Improve the Safety of RNAi Therapy for Huntington's Disease  Ryan L Boudreau,
Volume 26, Issue 7, Pages e4 (February 2019)
Volume 90, Issue 3, Pages (May 2016)
Volume 2, Issue 3, Pages (March 2014)
Anisha Gupta, Elias Quijano, Yanfeng Liu, Raman Bahal, Susan E
Fig. 3 Reduction of SUPT4H1 or SUPT5H in c9ALS fibroblasts inhibits production of C9orf72 variant 3 mRNA, sense and antisense RNA foci, and DPR proteins.
Volume 5, Issue 2, Pages (August 2015)
Volume 19, Issue 12, Pages (December 2011)
Nuclear Retention of mRNA in Mammalian Tissues
Volume 15, Issue 12, Pages (June 2016)
Volume 26, Issue 6, Pages (June 2018)
Volume 27, Issue 1, Pages (January 2019)
Volume 8, Issue 6, Pages (June 2017)
Volume 26, Issue 8, Pages (August 2018)
Volume 27, Issue 11, Pages e3 (June 2019)
Arati Sridharan, Chetan Patel, Jit Muthuswamy 
SUPT4H1 Depletion Leads to a Global Reduction in RNA
Chen Wu, Michelle E. Watts, Lee L. Rubin  Cell Reports 
Repulsive Guidance Molecule-a Is Involved in Th17-Cell-Induced Neurodegeneration in Autoimmune Encephalomyelitis  Shogo Tanabe, Toshihide Yamashita  Cell.
Volume 15, Issue 5, Pages (May 2007)
Volume 19, Issue 12, Pages (June 2017)
Presentation transcript:

Volume 24, Issue 10, Pages 2553-2560.e5 (September 2018) Nuclear Localization of Huntingtin mRNA Is Specific to Cells of Neuronal Origin  Marie-Cécile Didiot, Chantal M. Ferguson, Socheata Ly, Andrew H. Coles, Abigail O. Smith, Alicia A. Bicknell, Lauren M. Hall, Ellen Sapp, Dimas Echeverria, Athma A. Pai, Marian DiFiglia, Melissa J. Moore, Lawrence J. Hayward, Neil Aronin, Anastasia Khvorova  Cell Reports  Volume 24, Issue 10, Pages 2553-2560.e5 (September 2018) DOI: 10.1016/j.celrep.2018.07.106 Copyright © 2018 Terms and Conditions

Cell Reports 2018 24, 2553-2560.e5DOI: (10.1016/j.celrep.2018.07.106) Copyright © 2018 Terms and Conditions

Figure 1 Htt mRNA Is Highly Retained in the Nucleus in Cells of Neuronal Origin (A) Htt mRNA (green) detected in cells of non-neuronal origin (HeLa, Hm, and Mm primary fibroblasts) and in cells of neuronal origin (Mm Neuro2a, Mm cortical primary neurons, and Mm brain section) by dual-color FISH. Nuclei are labeled with Hoechst (blue). Representative images of maximum Z projections of optical sections through the nucleus are spaced 0.5 μm apart. 100× oil objective is shown (scale bars, 5 μm). (B) Scatterplot representing the absolute quantification of Htt transcript in each cell line. Each dot represents the number of nuclear and cytoplasmic foci for one cell (n = 20–30 cells). Linear regression is shown for each transcript. (C) Percentage of nuclear and cytoplasmic localization of Htt mRNA in different cell lines (n ∼20 cells; mean ± SEM; ∗∗∗∗p < 0.0001; one-way ANOVA-Bonferroni’s multiple comparisons test). See also Figure S2. Cell Reports 2018 24, 2553-2560.e5DOI: (10.1016/j.celrep.2018.07.106) Copyright © 2018 Terms and Conditions

Figure 2 A Large Fraction of Htt mRNA Is Localized in the Nucleus of Striatal and Cortical Neurons in Mouse Brain (A and B) Htt mRNA (green) detected in neurons (NeuN-positive cells, red) and glia (NeuN-negative cells) in the (A) striatum and the (B) cortex. Nuclei labeled with Hoechst (blue) are shown. Representative images are maximum Z projections of >20 optical sections spaced 0.5 μm apart. 100× oil objective for neuronal type cells is shown (scale bars, 5 μm). (C and D) Scatter graph of nuclear and cytoplasmic Htt mRNA foci in (C) the striatum and (D) the cortex (n = 20–30 cells; mean ± SEM; ∗p < 0.05; ∗∗p < 0.01; one-way ANOVA-Bonferroni’s multiple comparisons test). See also Figure S3. Cell Reports 2018 24, 2553-2560.e5DOI: (10.1016/j.celrep.2018.07.106) Copyright © 2018 Terms and Conditions

Figure 3 A Large Fraction of Htt mRNA Is Localized in the Nucleus of Fibroblast-Derived Neuron-like Cells (A) Scheme of fibroblasts conversion to neurons showing the neuronal morphology acquisition (adapted from Richner et al., 2015). (B) Phase contrast images of human primary fibroblasts transduced with miR-9/9∗-124 and CDM at post-induction dates (PIDs) 20. (C) Htt mRNA (green) was detected by FISH in Hs primary fibroblasts and Hs primary fibroblast-derived neuron-like cells. Nuclei labeled with Hoechst (blue) are shown. Representative images are maximum Z projections of >20 optical sections spaced 0.5 μm apart. 100× oil objective for neuronal type cells is shown (scale bars, 5 μm). (D) Scatterplot of nuclear and cytoplasmic Htt mRNA foci (n = 20–30 cells; mean ± SEM; ns, not significant; ∗∗∗∗p < 0.0001; one-way ANOVA-Bonferroni’s multiple comparisons test). (E) Percentage of nuclear and cytoplasmic localization for Htt transcript (n = 20–30 cells; mean ± SEM; ∗∗∗∗p < 0.0001; one-way ANOVA-Bonferroni’s multiple comparisons test). Cell Reports 2018 24, 2553-2560.e5DOI: (10.1016/j.celrep.2018.07.106) Copyright © 2018 Terms and Conditions

Figure 4 In Vivo Htt mRNA Silencing in Striatal Neurons by Hydrophobically Modified siRNA and Antisense Oligonucleotides DHA-siRNANTC, DHA-siRNAHTT, ASONTC, and ASOHTT (4 nmol in 2 μL; n = 3 animals per group) were administered by unilateral intrastriatal bolus microinjection. Brains were collected after 7 days, and Htt mRNA foci subcellular levels were assessed by FISH. (A) Schematic diagram of sagittal and coronal sections through the mouse striatum at the site of injection. The striatal region selected to acquire the images (red box) is indicated. (B and C) FISH detection of Htt mRNA (green) upon (B) DHA-siRNA and (C) ASO treatments. Nuclei labeled with Hoechst (blue) are shown. Representative images are maximum Z projections through the nuclear region spaced 0.5 μm apart. 100× oil objective is shown (scale bars, 5 μm). (D–F) Quantification of (D) Htt, (E) Hprt, and (F) Herc2 mRNA foci number. mRNA foci levels are presented as percentage of non-targeting control (n > 100 cells from 3 biological replicates; mean ± SEM; ∗∗∗∗p < 0.0001; one-way ANOVA-Bonferroni’s multiple comparisons test). ASO, antisense oligonucleotide; DHA-siRNA, docosahexaenoic acid-siRNA conjugate; NTC, non-targeting control; siRNA, small interfering RNA. See also Figure S4 and Table S2. Cell Reports 2018 24, 2553-2560.e5DOI: (10.1016/j.celrep.2018.07.106) Copyright © 2018 Terms and Conditions